Humanized animal models for autoimmune diseases

Tissue Antigens

Volumn 63, Issue 5, 2004, Pages 383-394

  Gregersen, J W ^a   Holmes, S ^b   Fugger, L ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Autoimmune disease; Celiac disease; Insulin dependent diabetes mellitus; MHC class II; Multiple sclerosis; Rheumatoid arthritis; T cell receptor; Transgenic mice

Indexed keywords

ANTIGEN; AUTOANTIGEN; GLIADIN; GLUTAMATE DECARBOXYLASE; GLUTEN; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PROTEOLIPID PROTEIN; SYNTHETIC PEPTIDE; T LYMPHOCYTE RECEPTOR;

ANIMAL MODEL; AUTOIMMUNE DISEASE; BRAIN INJURY; CELIAC DISEASE; CELL PROLIFERATION; CHRONIC ARTHRITIS; DEMYELINATION; DISEASE ACTIVITY; ENVIRONMENTAL FACTOR; GENE AMPLIFICATION; GENE EXPRESSION; HEREDITY; HISTOCOMPATIBILITY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INSULIN DEFICIENCY; INSULIN DEGRADATION; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SMALL INTESTINE DISEASE; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CELIAC DISEASE; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MICE; MICE, TRANSGENIC; MULTIPLE SCLEROSIS;

ANIMALIA; MUS MUSCULUS;

EID: 2442604214     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-2815.2004.00243.x     Document Type: Review

References (76)

1. Davnidson A, Diamond B. Autoimmune diseases. N Engl J Med 2001: 345: 340.
2. Sebzda E, Mariathasan S, Ohteki T, Jones R, Bachmann MF, Ohashi PS. Selection of the T cell repertoire. Annu Rev Immunol 1999: 17: 829.
3. Seddon B, Mason D. The third function of the thymus. Immunol Today 2000: 21: 95.
4. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis - an approach to understanding the molecular genetics of rheumatoid arthritis susceptibility. Arthritis Rheum 1987: 30: 1205.
5. Hammer JF, Gallazzi E, Bono RW et al. Peptide binding specificity of HLA-DR4 molecules: Correlation with rheumatoid arthritis association. J Exp Med 1995: 1: 1847.
6. Hammer J, Bono E, Gallazzi F, Belunis C, Nagy Z, Sinigaglia F. Precise prediction of major histocompatibility complex class II-peptide interaction based on peptide side chain scanning. J Exp Med 1994: 180: 2353.
7. Fujinami RS, Nelson JA, Walker L, Oldstone MB. Sequence homology and immunologic cross-reactivity of human cytomegalovirus with HLA-DR beta chain: a means for graft rejection and immunosuppression. J Virol 1988: 62: 100.
8. Roudier J, Rhodes G, Petersen J, Vaughan JH, Carson DA. The Epstein-Barr virus glycoprotein gp110, a molecular link between HLA DR4, HLA DR1, and rheumatoid arthritis. Scand J Immunol 1988: 27: 367.
9. + T cells. Cell Immunol 1992: 144: 347.
10. Cathcart ES, Hayes KC, Gonnerman WA, Lazzari AA, Franzblau C. Experimental arthritis in a nonhuman primate. I. Induction by bovine type II collagen. Lab Invest 1986: 54: 26.
11. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980: 283: 666.
12. Rubin AS, Healy CT, Martin LN, Baskin GB, Roberts ED. Experimental arthropathy induced in rhesus monkeys (Macaca mulatta) by intradermal immunization with native bovine type II collagen. Lab Invest 1987: 57: 524.
13. Trentham DE, Townes AS, Kang AH. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med 1977: 146: 857.
14. Zhang Y, Guerassimov A, Leroux JY et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice. Evidence for t cell involvement and the immunosuppressive influence of keratan sulfate on recognition of t and b cell epitopes. J Clin Invest 1998: 101: 1678.
15. Zhang Y, Guerassimov A, Leroux JY et al. Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998: 153: 1283.
16. Maccioni M, Zeder-Lutz G, Huang H et al. Arthritogenic monoclonal antibodies from K/ BxN mice. J Exp Med 2002: 195: 1071.
17. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996: 87: 811.
18. Matsumoto I, Staub A, Benoist C, Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999: 286: 1732.
19. Korganow AS, Ji H, Mangialaio S et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999: 10: 451.
20. Matsumoto I, Maccioni M, Lee DM et al. How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immun 2002: 3: 360.
21. Rosloniec EF, Brand DD, Myers LK et al. An HLA-DR1 Transgene Confers Susceptibility to Collagen-induced Arthritis Elicited with Human Type II Collagen. J Exp Med 1997: 185: 1113.
22. Andersson EC, Hansen BE, Jacobsen H et al. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 Tg mice. Proc Natl Acad Sci USA 1998: 95: 7574.
23. Fugger L, Rothbard J, McDevitt GS. Specificity of an HLA-DRB1*0401 restricted T cell response to type II collagen. Eur J Immund 1996: 26: 928.
24. Rosloniec EF, Whittington KB, Zaller DM, Rang AH. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen. J Immunol 2002: 168: 253.
25. Dessen A, Lawrence CM, Cupo S, Zaller DM, Wiley DC. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II. Immunity 1997: 7: 473.
26. Fugger L. Human autoimmunity genes in mice. Curr Opin Immunol 2000: 12: 698.
27. Wolley PH, Luthra HS, O'Duffy JD, Bunch TW, Moore SB, Stuart JM. Anti-type II collagen antibodies in rheumatoid arthritis. The influence of HLA phenotype. Tissue Antigens 1984: 23: 263.
28. Ronnelid J, Lysholm J, Engstrom-Laurent A, Klareskog L, Heyman B. Local anti-type II collagen antibody production in rheumatoid arthritis synovial fluid. Evidence for an HLA-DR4-restricted IgG response. Arthritis Rheum 1994: 37: 1023.
29. Fugger L. Joint-specific and systemic autoreactivity in the development of inflammatory arthritis. Arthritis Res 2000: 2: 2.
30. Backlund J, Carlsen S, Hoger T et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized Tg mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002: 99: 9960.
31. Myers LK, Sakurai Y, Tang B et al. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 Tg mice. Arthritis Rheum 2002: 46: 3369.
32. Wang D, Hill JA, Cairns E, Bell DA. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice. J Autoimmun 2002: 18: 95.
33. Taneja V, Taneja N, Behrens M et al. HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2A (q) and DRB1*0401 (DW4) Tg mice from arthritis. J Immunol 2003: 171: 4431.
34. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991: 38: 1.
35. Noseworthy JH. Progress in determining the causes and treatment of multiple sclerosis. Nature 1999: 399: A40.
36. Trotter JL, Hickey WF, van der Veen RC, Sulze L. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol 1991: 33: 55.
37. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990: 247: 718.
38. Hellings N, Baree M, Verhoeven C et al. T cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls. J Neurosci Res 2001: 63: 290.
39. Kerlero de Rosbo N, Milo R, Lees MB, Burger D, Bernard CC, Ben-Nun A. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein. J Clin Invest 1993: 92: 2602.
40. Wucherpfennig KW, Sette A, Southwood S et al. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med 1994: 179: 279.
41. Madsen LS, Andersson EC, Jansson L et al. A humanized model for multiple sclerosis utilizing HLA-DR2 and a human T cell receptor. Nature Genet 1999: 23: 343.
42. Krogsgaard M, Wucherpfennig KW, Canella B et al. Visualization of myelin basic protein (MBP) T cell epitopes in multiple sclerosis lesions using a monoclonal antibody specific for the human histocompatibility leukocyte antigen (HLA) -DR2-MBP 85-99 complex. J Exp Med 2000: 191: 1395.
43. Aharoni R, Teitelbaum D, Arnon R, Puri J. Immunomodulation of experimental allergic encephalomyelitis by antibodies to the antigen-Ia complex. Nature 1991: 351: 147.
44. Lang HL, Jacobsen H, Ikemizu S et al. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immun 2002: 3: 940.
45. Li Y, Li H, Martin R, Mariuzza RA. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol 2000: 304: 177.
46. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003: 100: 12877.
47. Sibley GN. An experimental model of detrusor instability in the obstructed pig. Br J Urol 1985: 57: 292.
48. Vandenbark AA, Rich C, Mooney J et al. Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 Tg mice. J Immunol 2003: 171: 127.
49. Burrows GG, Bebo BF Jr, Adlard KL, Vandenbark AA, Offner H. Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis. J Immunol 1998: 161: 5987.
50. Burrows GG, Adlard KL, Bebo BF Jr et al. Regulation of encephalitogenic T cells with recombinant TCR ligands. J Immunol 2000: 164: 6366.
51. Trotter JL, Pelfrey CM, Trotter AL et al. T cell recognition of myelin proteolipid protein and myelin proteolipid protein peptides in the peripheral blood of multiple sclerosis and control subjects. J Neuroimmunol 1998: 84: 172.
52. Ohashi T, Yamamura T, Inobe J, Kondo T, Kunishita T, Tabira T. Analysis of proteolipid protein (PLP)-specific T cells in multiple sclerosis: identification of PLP 95-116 as an HLA-DR2,w15-associated determinant. International Immunol 1995: 7: 1771.
53. Kawamura K, Yamamura T, Yokoyama K et al. HLA-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in Tg mice. J Clin Invest 2000: 105: 977.
54. Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. Myelin oligodendrocyte glycoprotein-specific T cell receptor Tg mice develop spontaneous autoimmune optic neuritis. J Exp Med 2003: 197: 1073.
55. Steinman L. Optic neuritis, a new variant of experimental encephalomyelitis, a durable model for all seasons, now in its seventieth year. J Exp Med 2003: 197: 1065.
56. Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell 1996: 85: 291.
57. Todd JA, Wicker LS. Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models. Immunity 2001: 15: 387.
58. Herman AE, Tisch RM, Patel SD et al. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif. J Immunol 1999: 163: 6275.
59. Liu J, Purdy LE, Rabinovitch S, Jevnikar AM, Elliott JF. Major DQ8-restricted T cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 Tg IA (null) NOD mice. Diabetes 1999: 48: 469.
60. Patel SD, Cope AP, Congia M et al. Identification of immunodominant T cell epitopes of human glutamic acid decarboxylase 65 using HLA-DR (a*10101, b*10401) Tg mice. Proc Natl Acad Sci USA 1997: 94: 8082.
61. Elliott JF, Liu J, Yuan ZN et al. Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 Tg IAbeta knockout NOD mice. Proc Natl Acad Sci USA 2003: 100: 13447.
62. Wen L, Wong FS, Tang J et al. In vivo evidence for the contribution of human histocompatibility leukocyte antigen (HLA)-DQ molecules to the development of diabetes. J Exp Med 2000: 191: 97.
63. Wen L, Chen NY, Tang J, Sherwin R, Wong FS. The regulatory role of DR4 in a spontaneous diabetes DQ8 Tg model. J Clin Invest 2001: 107: 871.
64. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002: 3: 235.
65. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000: 18: 53.
66. Farrell RJ, Kelly CP. Celiac sprue. N Engl J Med 2002: 346: 180.
67. Black KE, Murray JA, David CS. HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in Tg knockout mice. J Immunol 2002: 169: 5595.
68. Molberg O, McAdam SN, Korner R et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998: 4: 713.
69. Hahm KB, Im YH, Parks TW et al. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut 2001: 49: 190.
70. Bielekova B, Martin R. Antigen-specific immunomodulation via altered peptide ligands. J Mol Med 2001: 79: 552.
71. Cosgrove D, Gray D, Dierich A et al. Mice lacking MHC class II molecules. Cell 1991: 66: 1051.
72. Grusby MJ, Johnson RS, Papaioannou VE, Glimcher LH. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science 1991: 253: 1417.
73. Kontgen F, Suss G, Stewart C, Steinmetz M, Bhiethmann H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int Immunol 1993: 5: 957.
74. Madsen L, Labrecque N, Engberg J et al. Mice lacking all conventional MHC class II genes. Proc Natl Acad Sci U S A 1999: 96: 10338.
75. Chen D, Ueda R, Harding F et al. Characterization of HLA DR3/DQ2 Tg mice: a potential humanized animal model for autoimmune disease studies. Eur J Immunol 2003: 33: 172.
76. Jawaheer D, Li W, Graham RR et al. Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet 2002: 71: 585.